In den Genen liegt der Schlüssel: für jeden Patienten das richtige Medikament in der richtigen Dosis zur richtigen Zeit
Swiss-based BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics
Munich-based Lifescience-Startup ViGeneron announces closing of series A financing to drive development of next generation gene therapy pipeline
